Literature DB >> 9841853

Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants.

M B Martinez1, C R Taddei, A Ruiz-Tagle, L R Trabulsi, J A Girón.   

Abstract

Enteropathogenic Escherichia coli (EPEC) express a plasmid-encoded type IV pilus termed bundle-forming pilus, which is associated with the formation of bacterial microcolonies on cultured epithelial cells. Bacterial attachment and effacement of the enterocyte brush border membrane is attributed to a surface outer membrane protein adhesin termed intimin and EPEC-secreted proteins EspA, EspB, and EspD. Except for intimin, production in vivo or antibody response against these virulence determinants during natural EPEC infections in young children has not been demonstrated. Antibody responses against BfpA, intimin, EspA, and EspB were investigated in Brazilian children naturally infected with EPEC. Generally, IgG antibodies against BfpA and EspB were the most commonly found, followed by anti-EspA and intimin antibodies. Thus, bundle-forming pilus and locus of enterocyte attachment-encoded products are produced in vivo during natural EPEC infections and elicit an immune response against heterologous EPEC virulence determinants. These findings have important implications in the immunoprophylaxis against EPEC infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9841853     DOI: 10.1086/314549

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Expression of the bundle-forming pilus by enteropathogenic Escherichia coli strains of heterologous serotypes.

Authors:  Juana Gismero-Ordoñez; Monique Dall'Agnol; Luiz R Trabulsi; Jorge A Girón
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Novel topology of BfpE, a cytoplasmic membrane protein required for type IV fimbrial biogenesis in enteropathogenic Escherichia coli.

Authors:  T E Blank; M S Donnenberg
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

3.  Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination.

Authors:  Nobuhiko Kamada; Kei Sakamoto; Sang-Uk Seo; Melody Y Zeng; Yun-Gi Kim; Marilia Cascalho; Bruce A Vallance; José L Puente; Gabriel Núñez
Journal:  Cell Host Microbe       Date:  2015-04-30       Impact factor: 21.023

4.  Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies.

Authors:  A Parissi-Crivelli; J M Parissi-Crivelli; J A Girón
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.

Authors:  L J Gansheroff; M R Wachtel; A D O'Brien
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium.

Authors:  M Ghaem-Maghami; C P Simmons; S Daniell; M Pizza; D Lewis; G Frankel; G Dougan
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Identification, immunogenicity, and cross-reactivity of type IV pilin and pilin-like proteins from Clostridium difficile.

Authors:  Grace A Maldarelli; Leon De Masi; Erik C von Rosenvinge; Mihaela Carter; Michael S Donnenberg
Journal:  Pathog Dis       Date:  2014-02-18       Impact factor: 3.166

8.  Bovine colostrum contains immunoglobulin G antibodies against intimin, EspA, and EspB and inhibits hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli.

Authors:  Daniel A Vilte; Mariano Larzábal; Angel A Cataldi; Elsa C Mercado
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

9.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Human milk secretory antibodies against attaching and effacing Escherichia coli antigens.

Authors:  Marita Noguera-Obenza; Theresa J Ochoa; Henry F Gomez; M Lourdes Guerrero; Irene Herrera-Insua; Ardythe L Morrow; Guillermo Ruiz-Palacios; Larry K Pickering; Carlos A Guzman; Thomas G Cleary
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.